U.S. Industrials Stock News

NYSE:RACE
NYSE:RACEAuto

Ferrari Luce Puts Luxury EV Growth And Brand Scarcity To The Test

Ferrari (NYSE:RACE) is preparing to unveil its first full-electric vehicle, the Ferrari Luce. The launch marks a key step in the company’s move into ultra-premium electric vehicles while it continues to focus on profitability and exclusivity. The Luce is positioned as Ferrari’s entry into electric mobility alongside its broader product diversification efforts. For you as an investor, Ferrari sits in a very specific corner of the auto market, focused on high-end performance cars with tight...
NYSE:BLSH
NYSE:BLSHCapital Markets

ARK Invest Buying And New York BitLicense Shape Bullish Outlook

ARK Invest has purchased NYSE:BLSH shares for ten consecutive trading days, signaling ongoing institutional interest. Bullish recently secured approval for a New York BitLicense, expanding its regulatory footprint in a key U.S. market. The BitLicense allows Bullish to broaden custody services and access a wider pool of professional clients in New York. For Bullish, ticker NYSE:BLSH, the combination of steady ARK Invest buying and a New York BitLicense arrives at a time when the broader...
NYSE:TME
NYSE:TMEEntertainment

Tencent Music Entertainment Group (NYSE:TME) Valuation After Stimulus Driven Share Price Jump

Tencent Music Entertainment Group (NYSE:TME) jumped 15.7% after China announced its largest stimulus package since the pandemic. The measures include interest rate cuts and looser mortgage rules that lifted sentiment toward Chinese consumer tech names. See our latest analysis for Tencent Music Entertainment Group. The latest jump comes after a weaker few months, with a 30 day share price return of a 4.4% decline and a 90 day share price return of a 16.1% decline, even as the 1 year total...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

A Look At Palo Alto Networks (PANW) Valuation After Recent Share Price Pullback

Recent performance snapshot for Palo Alto Networks (PANW) Palo Alto Networks (PANW) has drawn attention after a mixed recent return profile, with gains over the past week but negative moves over the past month and past 3 months, prompting a closer look at its fundamentals. See our latest analysis for Palo Alto Networks. At a share price of $166.95, Palo Alto Networks has seen short term momentum pick up, with a 1 day share price return of 2.54% and 7 day share price return of 4.79%. This...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum

With no single headline event driving it today, 10x Genomics (TXG) is experiencing a combination of mixed recent share returns and ongoing interest in its genomics tools business, prompting closer attention from investors. See our latest analysis for 10x Genomics. The recent 3.5% 1 day share price gain to US$18.12 sits against a 30 day share price return of 12% and a 1 year total shareholder return of 47%. However, the 3 and 5 year total shareholder returns remain sharply negative, suggesting...
NYSE:SNA
NYSE:SNAMachinery

How Investors Are Reacting To Snap-on (SNA) Solid Q4 Results And Steady Dividend Amid Softer Sales

Snap-on reported fourth-quarter 2025 results with sales of US$1,231.9 million and diluted EPS of US$4.94, alongside a US$2.44 quarterly dividend declared for payment on March 10, 2026 to shareholders of record on February 24, 2026. While revenue growth was modest and earnings eased slightly for the full year, Snap-on’s uninterrupted quarterly dividend record since 1939 underscores how management is prioritizing consistent shareholder returns amid a turbulent demand backdrop. Now we’ll assess...
NYSE:PHIN
NYSE:PHINAuto Components

PHINIA Growth Story Links 2025 Execution With 2026 Transition Goals

PHINIA Inc. (NYSE:PHIN) reported year over year growth across key business segments in 2025. The company recorded three consecutive quarters of growth in both Fuel Systems and Aftermarket segments. Management reduced debt, improved leverage, and expressed optimism for 2026. Leadership is targeting further market share gains in areas such as Gasoline Direct Injection and alternative fuels. PHINIA, trading as NYSE:PHIN, focuses on Fuel Systems and Aftermarket products that support internal...
NYSE:MRK
NYSE:MRKPharmaceuticals

A Look At Merck (MRK) Valuation After New Keytruda Approval And Oncology Data Updates

Why Merck stock is back in focus Merck (MRK) is back on investors radars after the FDA approved KEYTRUDA and its subcutaneous QLEX formulation for platinum-resistant ovarian cancer, alongside fresh oncology data heading to the 2026 ASCO GU symposium. This new indication makes KEYTRUDA the first PD-1 inhibitor cleared for this difficult ovarian cancer population, supported by Phase 3 results. The upcoming genitourinary presentations highlight how central oncology remains to Merck's long-term...
NasdaqGS:CIFR
NasdaqGS:CIFRSoftware

Assessing Cipher Mining (CIFR) Valuation As AI Data Center Deals And HPC Expansion Gain Traction

Cipher Mining (CIFR) is reshaping its business beyond crypto mining, anchored by a US$3b, 10-year Fluidstack partnership for AI focused data centers and a US$2b private placement backing its Black Pearl high performance computing facility. See our latest analysis for Cipher Mining. At a share price of US$16.42, Cipher Mining has seen momentum swing around its news flow, with an 11.47% 7 day share price return and a 14.43% 90 day share price return sitting alongside a 1 year total shareholder...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Is It Time To Reassess Alkermes (ALKS) After Mixed Share Price Performance?

If you are wondering whether Alkermes at around US$33.16 is offering good value right now, this article will walk through what the numbers actually suggest. The share price performance shows a mixed picture, with a 5% decline over the last 7 days, a 4.8% gain over the last 30 days, a 17.3% gain year to date, and a 7.6% decline over the last year alongside gains of 20.1% over 3 years and 72.1% over 5 years. Recent coverage has focused on Alkermes as a long established player in the...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

How Investors Are Reacting To Match Group (MTCH) Flat 2026 Outlook Amid AI Push And Capital Returns

Match Group reported past fourth-quarter 2025 sales of US$878.01 million and net income of US$209.65 million, alongside full-year 2025 sales of US$3.49 billion and a higher annual profit, while also updating its 2026 revenue outlook to be roughly flat year-on-year. Alongside the earnings release, Match Group raised its quarterly dividend, completed a sizeable share repurchase program, and highlighted cost savings that are being redirected into AI-driven product innovation and...
NYSE:ABM
NYSE:ABMCommercial Services

Assessing ABM Industries (ABM) Valuation After Recent Share Price Volatility

What ABM Industries (ABM) investors may be watching now ABM Industries (ABM) recently closed at $44.51, with shares showing a 2.46% move over the past day, a small decline over the past month, and a gain across the past 3 months. See our latest analysis for ABM Industries. That 2.46% 1 day share price gain comes after a 6.41% 7 day share price pullback. The 90 day share price return of 10.42% suggests momentum has been rebuilding even as the 1 year total shareholder return of 13.92% remains...
NYSE:NOW
NYSE:NOWSoftware

Is ServiceNow (NOW) Quietly Recasting Itself as the AI Workflow Control Tower of the Enterprise?

In recent days, ServiceNow has accelerated its AI push through new alliances such as Kearney’s BPR.ai offering, multiple AI-focused acquisitions, and the appointment of Danielle Fontaine as Chief Accounting Officer and Corporate Controller following her prior role as Assistant Controller. Together with upbeat analyst research and growing ecosystem activity on its platform, these moves highlight how ServiceNow is being framed as an AI workflow “control tower” rather than a software company at...
NasdaqCM:FONR
NasdaqCM:FONRMedical Equipment

Fonar (FONR) Margin Compression To 6.7% Reinforces Profitability Concerns After Q2 2026 Results

FONAR (FONR) has just posted its Q2 2026 numbers, with quarterly revenue of about US$26 million and basic EPS of US$0.33, setting the stage against a year of trailing EPS of roughly US$1.08 on revenue of about US$105 million. Over recent quarters, the company has seen revenue move between roughly US$24.9 million and US$27.3 million, while quarterly EPS has ranged from about US$0.11 to US$0.46. This has left investors focused on how these latest figures feed into a story of compressing margins...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Costco (COST) Valuation Check After 9.3% January Sales Growth And Rising E Commerce Contribution

Costco Wholesale (COST) is back in focus after reporting January net sales of US$21.33b, up 9.3% year over year, with digital and e-commerce channels taking a larger share of revenue. See our latest analysis for Costco Wholesale. The latest US$21.33b January sales update and growing digital mix come on top of strong price momentum, with Costco’s 30 day share price return of 5.69% and year to date share price return of 19.19%, while its 3 year total shareholder return of 109.03% contrasts with...
NYSE:BIO
NYSE:BIOLife Sciences

Assessing Bio-Rad (BIO) Valuation After Recent Share Price Weakness And Longer-Term Return Pressures

Recent trading in Bio-Rad Laboratories (BIO) has drawn attention after a series of negative returns over the past month and past 3 months, prompting investors to reassess what the current share price may already reflect. See our latest analysis for Bio-Rad Laboratories. With the share price at US$256.56 after a 12.26% one-day and 18.17% 30-day share price decline, recent weakness sits against a longer backdrop of pressured total shareholder returns, including a 46.91% 3-year and 59.72%...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Exelon (EXC) Is Up 9.4% After Dividend Hike And $41.3B Grid Plan Announcement - Has The Bull Case Changed?

Exelon Corporation recently reported fourth-quarter 2025 results showing sales of US$5,412 million and net income of US$593 million, alongside full-year 2025 sales of US$24.26 billion and net income of US$2.77 billion, and its Board declared a regular quarterly dividend of US$0.42 per share payable in March 2026. These earnings beats, paired with an increased dividend and a US$41.30 billion long-term grid and transmission investment plan, highlight Exelon’s focus on regulated infrastructure...
NYSE:NVT
NYSE:NVTElectrical

A Look At nVent Electric (NVT) Valuation After Robust Earnings And Confident Datacenter Outlook

nVent Electric (NVT) is back in focus after reporting fourth quarter and full year 2025 results that paired sharp year over year growth in sales and earnings with renewed analyst confidence. See our latest analysis for nVent Electric. At a share price of $113.25, nVent Electric has seen an 8.8% 90 day share price return and a very strong 1 year total shareholder return of 67.43%, which points to momentum building around its earnings progress, datacenter exposure and acquisition pipeline, even...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Assessing Monolithic Power Systems (MPWR) Valuation After Record Earnings Beat And Strong Data Center Demand

What the latest quarter means for Monolithic Power Systems stock Monolithic Power Systems (MPWR) just posted record quarterly revenue and earnings that came in ahead of analyst expectations, with demand in enterprise data, communications, and automotive driving the story and helping explain the recent share move. See our latest analysis for Monolithic Power Systems. At a share price of US$1,171.47, Monolithic Power Systems has a 30-day share price return of 13.39% and a 90-day share price...
NasdaqGS:CFLT
NasdaqGS:CFLTSoftware

IBM Deal Sets Floor Under Confluent Growth Story And Ongoing Risks

IBM has agreed to acquire Confluent in a definitive deal, bringing the data streaming specialist into its broader enterprise software portfolio. The agreement follows strong quarterly revenue and earnings results from Confluent, which trades under ticker NasdaqGS:CFLT. The transaction marks a major ownership shift for Confluent shareholders at a current share price of $30.56. For investors watching NasdaqGS:CFLT, this deal comes after a mixed share price record, with the stock up 20.5% over...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

A Look At Rigetti Computing (RGTI) Valuation After TD Cowen Downgrade And Funding Concerns

Rigetti Computing (RGTI) is back in focus after a TD Cowen downgrade, with the firm highlighting more than US$300 million in potential fabrication funding needs, rising competitive pressure, and the company’s absence from DARPA QBI Stage B participation. See our latest analysis for Rigetti Computing. The TD Cowen downgrade comes after a sharp reset in Rigetti’s momentum, with a 37.2% 1 month share price return decline and a 31.8% year to date share price return drop, even though the 3 year...
NasdaqGS:SAIA
NasdaqGS:SAIATransportation

Why Saia (SAIA) Is Down 7.4% After Record Q4 Revenue But Weaker Profitability And EPS

In February 2026, Saia, Inc. reported fourth-quarter 2025 revenue of US$789.95 million, roughly flat year on year, while net income fell to US$47.52 million and diluted earnings per share from continuing operations declined to US$1.77. Despite recording record quarterly revenue and completing its first full year as a national network, Saia’s profitability weakened as higher self-insurance costs and a softer freight backdrop pushed its operating ratio to 91.9%. Now we’ll explore how Saia’s...
NYSE:NABL
NYSE:NABLSoftware

Assessing N-able (NABL) Valuation After Recent Share Price Weakness And Fair Value Gap

Why N-able (NABL) is on investors’ radar N-able (NABL) has drawn investor attention after recent trading left the stock at US$5.35, with returns over the past month and past 3 months under pressure and the 1 year total return also negative. With annual revenue of US$497.665 million and net income reported as a US$6.511 million loss, the company’s value score of 6 and an indicated intrinsic discount provide a starting point for investors assessing risk and potential reward. See our latest...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Madrigal Pharmaceuticals (MDGL) Pricing Look Attractive After Recent Share Price Pullback

If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, you will want to look beyond the share price and consider what different valuation methods are signaling. The stock closed at US$464.71, with a 2.7% decline over 7 days, a 7.4% decline over 30 days, a 21.7% decline year to date, a 37.8% gain over 1 year, a 53.2% gain over 3 years, and a 281.3% gain over 5 years. These figures can influence how investors think about both upside potential and...